Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Proteomics

• Publication date

  2010-04-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jprot.2010.01.008PMID 20102753PMCID PMC2856840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

  2009cited by this paper
• Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

  2008cited by this paper
• Human Kallikrein-related Peptidase 14 (KLK14) Is a New Activator Component of the KLK Proteolytic Cascade

  2008cited by this paper
• Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?

  2006cited by this paper
• Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate

  2004cited by this paper
• Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.

  2001cited by this paper
• Seminal plasma contains “BPSA,” a molecular form of prostate‐specific antigen that is associated with benign prostatic hyperplasia

  2000cited by this paper
• Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen.

  1999cited by this paper
• Molecular Heterogeneity of Free PSA in Sera of Patients with Benign and Malignant Prostate Tumors

  1999cited by this paper
• Prostate-specific antigen.

  1999cited by this paper
• Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

  1997cited by this paper
• Characterization of the Precursor of Prostate-specific Antigen

  1997cited by this paper
• Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.

  1995cited by this paper
• Ultrasensitive bioanalytical assays using time-resolved fluorescence detection.

  1995cited by this paper
• Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.

  1994cited by this paper
• Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.

  1992cited by this paper
• A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

  1991cited by this paper
• Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

  1991cited by this paper
• Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.

  1991cited by this paper
• Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

  1990cited by this paper
• Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.

  1987cited by this paper
• Molecular cloning of human prostate specific antigen cDNA

  1987cited by this paper
• Prostate-specific antigen.

  1987cited by this paper
• Human prostate-specific antigen: structural and functional similarity with serine proteases.

  1986cited by this paper
• A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

  1985cited by this paper

• MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate Cancer

  2025cites this paper
• Targeted and Untargeted Proteomics Approaches in Biomarker Development

  2019cites this paper
• Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy

  2017cites this paper
• Optimized production, quality control, biological evaluation and PET/CT imaging of 68Ga-PSMA-617 in breast adenocarcinoma model

  2017cites this paper
• Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface.

  2016cites this paper
• Development of glycan specific lectin based immunoassay for detection of prostate specific antigen.

  2016cites this paper
• On-Chip Mass Spectrometry-Based Immunoassay as a Tool for the Detection of Molecular Species from Prostate-Specific Antigen in Female Serum

  2016cites this paper
• Short report Open Access

  2015cites this paper
• Improving the early diagnostic of prostate cancer by multiple biomarker detection with new biosensing devices

  2015cites this paper
• Proteomic Identification and Systematic Verification of Biomarkers for Aggressive Prostate Cancer

  2015cites this paper
• MALDI-target integrated platform for affinity-captured protein digestion.

  2014cites this paper
• In Vitro Selection of DNA Aptamers Against Prostate Cancer Peptide Biomarkers

  2014cites this paper
• On chip immuno-af fi nity pro fi ling of cancer-and benign hyperplasia-associated free prostate speci fi c antigen

  2014cites this paper
• Evaluation of Molecular Species of Prostate-Specific Antigen Complexed with Immunoglobulin M in Prostate Cancer and Benign Prostatic Hyperplasia

  2013cites this paper
• Interlaboratory Study on Differential Analysis of Protein Glycosylation by Mass Spectrometry: The ABRF Glycoprotein Research Multi-Institutional Study 2012*

  2013cites this paper
• Clinical and Biomedical Mass Spectrometry: New Frontiers in Drug Developments and Diagnosis

  2013cites this paper
• Al·lèrgia al líquid seminal, reactivitat encreuada amb caspa de gos i caracterització dels al!lèrgens implicats

  2012cites this paper
• Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.

  2012cites this paper
• Purification and characterization of a native zinc-binding high molecular weight multiprotein complex from human seminal plasma.

  2011cites this paper
• Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples.

  2011cites this paper
• Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels

  2011cites this paper
• Biobank resources for future patient care: developments, principles and concepts

  2011cites this paper
• On Chip Immuno-Affinity Profiling of Cancer- and Benign Hyperplasia-Associated Free Prostate Specific Antigen

  2011cites this paper
• CE methods for analysis of isoforms of prostate‐specific antigen compatible with online derivatization for LIF detection

  2011cites this paper
• Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer.

  2010cites this paper
• Expanding the mouse embryonic stem cell proteome: Combining three proteomic approaches

  2010cites this paper